A novel way to identify and sort cells. Our mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease. Our platform identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. Because our AI-powered technology can isolate and capture virtually any cell population based on morphological features, it can be used for a wide variety of research and translational applications.Deepcell technology allows researchers to characterize tissue composition at the cellular level by sorting cells based on morphology and supporting downstream analysis. Deepcell technology allows enrichment of specific cell populations for further post processes. Using Deepcell technology, cells in concentrations as low as one in a billion can be identified and isolated. We combine state-of-the-art machine learning, microfluidics, imaging, and genomics to power phenotype activated cell analysis and sorting. Our technology identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. The technology allows for the delivery of intact and viable single cells at high precision with no bias. Unlike other approaches, our platform maintains cell viability for downstream characterization. It can be used to isolate any type of cell, even those occurring at frequencies as low as one in a billion. Our continuously learning AI can differentiate cells without inherent bias, allowing for more robust science. By basing classification on morphological differences that may be invisible to the human eye, Deepcell allows for serendipitous discovery. Our unique microfluidics platform sorts cells gently, ensuring viability for downstream analysis.